<DOC>
	<DOCNO>NCT00211900</DOCNO>
	<brief_summary>This study answer U.S. Food Drug Administration requirement evaluation people manufacture lot vaccine . Subjects receive one dose one lot vaccine . The antibody blood measure immunogenicity vaccine , typical vaccine safety information also collect .</brief_summary>
	<brief_title>Evaluation Manufacturing Lot StaphVAX</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>8 wk hemodialysis ESRD , write informed consent , negative serum pregnancy test appropriate , expect comply protocol procedure schedule know HIV , immunomodulatory drug , malignancy ( basal cell squamous cell carcinoma , carcinoma situ cervix , early stage prostate cancer ) , active infection 2 week prior study injection , serious S. aureus infection within last 3 month prior injection , use investigational drug , vaccine device within prior 30 day , hypersensitivity component StaphVAX</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>